A new pill to lower blood sugar for people with type 2 diabetes for 1 last update 12 Jul 2020 was approved by the U.S. Food and Drug Administration.A new pill to lower blood sugar for people with type 2 diabetes was approved by the U.S. Food and Drug Administration.
The drug, Rybelsus, with the active ingredient semaglutide, is the first pill in a class of drugs called glucagon-like peptide, GLP-1, approved for use in the 1 last update 12 Jul 2020 the United States. Before Rybelsus, the drug had to be injected.
"" said Dr. Lisa Yanoff in an agency news release Friday. She is acting director of the Division of Metabolism and Endocrinology Products in the FDA''s weekly injection Trulicity. Glucose-lowering pills in other classes include Januvia and Jardiance.
GLP-1 is a hormone often found in low levels in people with type 2 diabetes. Rybelsus acts by slowing digestion and preventing the liver from making too much sugar, which helps the pancreas produce more insulin.
In clinical trials, Rybelsus significantly lowered blood sugar.
After 26 weeks, 77 percent of patients taking 14 mg of Rybelsus daily saw their HbA1C drop below 7 percent compared with 31 percent among those receiving a placebo. HbA1C is a measure of blood sugar.
Rybelsus is not recommended as the first choice for treating diabetes, the FDA said.
The drug has potential risks. It may cause certain thyroid tumors. Patients who have had thyroid cancer or have a relative who has had it are advised not to take Rybelsus.
blood sugar levels of 500 symptoms limits (👍 vegan) | blood sugar levels of 500 symptoms questionnairehow to blood sugar levels of 500 symptoms for Rybelsus is also not for people with type 1 diabetes or diabetic ketoacidosis. The drug label also warns about inflammation of the pancreas, vision loss, low blood sugar and kidney injury.
blood sugar levels of 500 symptoms in a sentence (☑ is caused by) | blood sugar levels of 500 symptoms kidney failurehow to blood sugar levels of 500 symptoms for The most common side effects are nausea, diarrhea, vomiting, decreased appetite, indigestion and constipation, the FDA noted.
For more on type 2 diabetes, see the American Diabetes Association.
Copyright 2019 HealthDay. All rights reserved.